Recurrent platinum drug resistant Fallopian tube cancer

Recurrent Platinum Drug Resistant Fallopian Tube Cancer: What You Need To Know

Fallopian tube cancer is a rare type of cancer in women, and recurrent platinum drug-resistant fallopian tube cancer is rarer still. When the cancer returns after treatment and fails to respond to platinum-based drugs, it is considered to be recurrent platinum drug-resistant fallopian tube cancer.

Because of the rarity of this disease, little is known about its causes, symptoms, progression, and best treatment options. That’s why it’s essential to have an experienced and knowledgeable healthcare provider in your corner when dealing with recurrent platinum drug-resistant fallopian tube cancer.

Types of Fallopian Tube Cancer

Most fallopian tube cancers are epithelial tumors—that is, they originate from the cell lining of the fallopian tube. These can start as benign noncancerous tumors, known as border epithelial tumors, that can become cancerous. Generally, the cancer will start in the cells lining the fallopian tubes, before spreading to other parts of the body.

Signs and Symptoms of Recurrent Platinum Drug Resistant Fallopian Tube Cancer

The most common symptom of recurrent platinum drug-resistant fallopian tube cancer is abdominal pelvic pain. Other symptoms can include abnormal vaginal bleeding or discharge, bloating or pressure in the pelvis, trouble urinating, constipation, and weight loss. More rare symptoms can be pain in the legs, bones, and lungs.

Diagnosis of Recurrent Platinum Drug Resistant Fallopian Tube Cancer

Your healthcare provider will likely order a CT scan to look for tumors in your abdomen and pelvis. They may also order an MRI or PET scan, as well as X-rays. In order to stage the cancer, they may also do a pelvic exam and order a biopsy of the tumor. Blood and urine tests may also be done to get a better view of the body’s health.

Treatment Options for Recurrent Platinum Drug Resistant Fallopian Tube Cancer

Treatments for recurrent platinum drug-resistant fallopian tube cancer will vary based on the type of cancer, how advanced it is, and other factors. Treatment options may include:

  • Surgery to remove the tumor or parts of the fallopian tube
  • Chemotherapy, especially with new or experimental agents
  • Radiation to shrink tumors
  • Targeted therapies such as monoclonal antibodies or small molecule inhibitors

Patients may also consider clinical trials, or participate in research to identify new or better treatments for recurrent platinum drug-resistant fallopian tube cancer.

Conclusion

If you have been diagnosed with recurrent platinum drug-resistant fallopian tube cancer, it’s essential to assemble a healthcare team with experience in treating this rare form of cancer. Talk with your team about the best treatment option for you, and be sure to ask about clinical trials and research opportunities to potentially help you and others who may have this form of cancer.